Center of General Surgery and Liver Transplant, Fundeni Clinical Institute, Bucharest, Romania.
Dig Surg. 2012;29(5):400-7. doi: 10.1159/000343927. Epub 2012 Nov 2.
BACKGROUND/AIM: The aim of the present study is to compare the postoperative and long-term outcomes of central pancreatectomy (CP) and spleen-preserving distal pancreatectomy (SPDP).
Clinical, pathological and long-term data were compared between 22 patients who underwent CP and 25 patients who underwent SPDP (2002-2012).
The median length of resected pancreas was 8.5 cm in the SPDP group and 5 cm in the CP group (p < 0.001). The median estimated blood loss was significantly lower in the CP group (p = 0.019). Morbidity was 50% for CPs and 40% for SPDPs (p = 0.564). The rate of pancreatic fistulae was 36% for CPs and 40% for SPDPs (p = 0.530). The rate of new-onset diabetes was nil in the successful CP group and 16% in the SPDP group (p = 0.111).
Morbidity and pancreatic fistula rates are not higher after CP when compared to SPDP. The loss of normal pancreatic tissue is significantly lower for CP, and thus there is potentially better preservation of the pancreatic endocrine functions. CP should be considered only in selected cases when preservation of the pancreas is of utmost importance, especially for lesions situated at the level of the pancreatic neck.
背景/目的:本研究旨在比较中央胰腺切除术(CP)和保留脾脏的胰体尾切除术(SPDP)的术后和长期结果。
比较了 2002 年至 2012 年间 22 例行 CP 患者和 25 例行 SPDP 患者的临床、病理和长期数据。
SPDP 组的胰腺切除长度中位数为 8.5cm,CP 组为 5cm(p<0.001)。CP 组的中位估计出血量明显较低(p=0.019)。CP 的发病率为 50%,SPDP 为 40%(p=0.564)。CP 的胰瘘发生率为 36%,SPDP 为 40%(p=0.530)。成功的 CP 组新发糖尿病发生率为 0%,SPDP 组为 16%(p=0.111)。
与 SPDP 相比,CP 后的发病率和胰瘘发生率并不高。CP 切除的正常胰腺组织明显减少,因此胰腺内分泌功能的保护可能更好。CP 仅应在保留胰腺至关重要的情况下选择性使用,尤其是对于胰腺颈部水平的病变。